A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)
Clinical trial NCT00314574 · COMPLETED
Trial details
- NCT number
- NCT00314574
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2009-11-01
- Enrollment
- 850
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.